Sign in
CompletedNo phase

Narcolepsy Nightmare Study

Key facts

Who runs it
Northwestern University
Where
Chicago, United StatesSee the site
Trial code
Status
Completed
People taking part
7 people enrolled
Started
22 Feb 2023
Ended
30 Apr 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Imagery rehearsal therapy
  • Targeted dream control
Record updated
30 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Diagnosis of narcolepsy
  • Age 18 or older
  • Speak English
  • Live in the United States
  • Receiving standard medical care for narcolepsy
  • Sleep and psychiatric medications stable for at least 3 months
  • Nightmare frequency of ≥3 times per week
  • Nightmare Disorder Index score indicates probable nightmare disorder
  • Able to attend a study appointment in Evanston, IL
  • Able and willing to not take wake-promoting medications on day of lab visit

Who cannot take part

  • Previous behavioral treatment for nightmares
  • History of a neurological disorder that might alter EEG
  • Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment
  • Currently engaged in sleep- or trauma-focused psychotherapy
  • Untreated sleep apnea (AHI ≥ 5)

Where in United States

  • Northwestern UniversityChicago, United States

About the trial

What the trial wants to find out

The goal of this clinical trial is to test two behavioral treatments for nightmares in adults with narcolepsy. The main questions it aims to answer are:

Read full original descriptionShow less

* Is imagery rehearsal therapy (IRT) effective for narcolepsy-related nightmares? * Does adding targeted dream control (TDC) to IRT make it more effective?

Participants will be randomized to one of two treatment groups and will be asked to:

* Complete a daily log of sleep symptoms for up to 13 weeks. * Attend 7 sessions of treatment. * Complete questionnaires before and after treatment. * Go to the research lab in Evanston, IL to complete a sleep study during a daytime nap (Chicago area residents only).

The 2 groups in the trial

  • Imagery rehearsal therapy (IRT)Treatment being tested

    Participants randomized to this group will receive 7 sessions of IRT.

    Treatment: Imagery rehearsal therapy

  • Imagery rehearsal therapy and targeted dream control (IRT+TDC)Treatment being tested

    Participants randomized to this group will receive 7 sessions of IRT+TDC.

    Treatment: Imagery rehearsal therapy and Targeted dream control

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Behavioral Treatment of Narcolepsy-Related Nightmares
Record updated
30 June 2026